- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02512159
Skin Ulcers Treatment With an Handicraft Topical Device
July 29, 2015 updated by: Coordinación de Investigación en Salud, Mexico
Effectiveness of Topical Negative Handicraft Device for Versus Traditional Conservative Treatment in Skin Ulcers Management in Lower Limb
The aim of this study was to evaluate the efficacy of a handicraft topical device of negative pressure versus traditional healing treatment for skin ulcers in lower limbs; in patients with diabetes mellitus, venous stasis and arterial insufficiency.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The hypothesis of this trial is that the handicraft topical device of negative pressure is even better for the treatment of skin ulcers located in the lower limbs of patients with diabetes mellitus, venous stasis and arterial insufficiency.
We anticipate that in a sample of 144 patients with ulcer, will heal or at least improve with this treatment
Study Type
Interventional
Enrollment (Actual)
144
Phase
- Phase 4
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with cutaneous leg ulcers due to diabetes mellitus, venous stasis and arterial insufficiency requiring healing or tissue debrided sent to managing their disease to regional general hospital No. 17, Instituto Mexicano del Seguro Social, Benito Juárez, Quintana Roo.
- Patients of both sexes.
- Patients over 18 years.
- Patients that have basic laboratory at admission (complete blood count with differential).
- Patients with comorbidities associated as Diabetes Mellitus , Hypertension, stroke, heart disease, nephropathy, venous insufficiency and arterial insufficiency, etc.
Exclusion Criteria:
- Hemodynamically unstable patients.
- Patients with septic shock from any source.
- Patients with deep skin ulcers with exposed some organ, data osteomyelitis, vascular-nervous exposure.
- Patients with secondary cutaneous ulcer enteral fistula.
- Patients with cutaneous ulcer or cancer tumors.
- Patients with cutaneous ulcer with active bleeding.
- Patients with cutaneous ulcer necrosis.
- Patients with cutaneous ulcer leishmania, insect bite.
- Patients with cutaneous ulcer burns.
- Patients who do not accept their participation in the study through informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: drenovac handcrafted
Patients treatment with the handicraft topical device negative pressure therapy Economic craft
|
under local anesthesia, sepsis and antisepsis, place sterile field, prepared area go out all devitalized or necrotic tissue using liquid soap surgical and irrigation back saline 0.9%.
We introduce a device to distribute the negative pressure or vacuum on ulcer; conducted margins make recommendations 5-12 mm over the edge of the wound, applying negative pressure or vacuum retracted sponges, likewise for the spare fewer gauze was placed Sterile adhesive film covering the defect to seal the system cover adequately the probe output nelaton not to submit drain the system.
Connect the probe to the sterile nelaton this hose and a suction system with pressure gauge, pressure -80-125 mmHg.
Change it every 72 hours.
|
|
Active Comparator: Healing
Patients who were managed with traditional "conservative treatment".
|
Were handled as follows:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of granulation tissue in skin ulcers.
Time Frame: 10 days
|
Presence of granulation tissue in 50% of the wound
|
10 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Leukocyte less than 11,000 mm3.
Time Frame: 10 days
|
Leukocyte less than 11,000 mm3.
|
10 days
|
|
Temperature
Time Frame: 10 days
|
less than 38 ° C temperature.
|
10 days
|
|
Breathing Rate
Time Frame: 10 days
|
less than 20 rpm breathing rate.
|
10 days
|
|
Heart Rate
Time Frame: 10 days
|
lower heart rate 90 bpm.
|
10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Fany Guadalupe Pat Espadas, MCs, IMSS
- Study Chair: Israel Augusto González González, Dr., IMSS
- Study Director: Luis Sandoval Jurado, PhD, IMSS
- Study Chair: Ma. Valeria Jiménez Baéz, PhD, IMSS
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Actual)
October 1, 2014
Study Completion (Actual)
January 1, 2015
Study Registration Dates
First Submitted
March 12, 2015
First Submitted That Met QC Criteria
July 29, 2015
First Posted (Estimate)
July 30, 2015
Study Record Updates
Last Update Posted (Estimate)
July 30, 2015
Last Update Submitted That Met QC Criteria
July 29, 2015
Last Verified
February 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014-2301-12
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Foot Ulcer
-
ConvaTec Inc.CompletedWound Infection | Ulcer Foot | Ulcer Healing
-
Universidad del DesarrolloFundación Instituto Nacional de HeridasRecruitingUlcer Foot | Ulcer VenousChile
-
BioLab HoldingsSerena GroupRecruitingUlcer | Diabetic Foot Ulcer | Venous Leg Ulcer | Leg Ulcers | Venous Ulcer | Ulcer Foot | Venous Leg Ulcer (VLU) | Foot Ulcer Chronic | DFUUnited States
-
StimLabsNot yet recruitingDiabetic Foot | Foot Ulcer | Ulcer Foot | Diabetic Foot Ulcer (DFU)
-
DEBx Medical B.V.Not yet recruitingDiabetic Foot Wounds | Diabetic Foot Ulcer (DFU) | Diabetic Foot Ulcer Treatment
-
Applied Biologics, LLCSerenaGroup, Inc.RecruitingDiabetic Foot | Foot Ulcer | Diabetic Foot Ulcer | Ulcer Foot | Foot Ulcer Due to Type 1 Diabetes Mellitus | Foot Ulcer Due to Type 2 Diabetes Mellitus | DFUUnited States
-
Applied Biologics, LLCSerena GroupRecruitingUlcer | Diabetic Foot Ulcer | Diabetic Foot Ulcers (DFU) | Foot Ulcer ChronicUnited States
-
State University of New York at BuffaloNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Recruiting
-
University of PittsburghSociety for Vascular SurgeryTerminatedIschemic Foot UlcerUnited States
-
Zagazig UniversityCompletedUlcer Foot | Chronic Skin Ulcer | Non-Healing Ulcer of SkinEgypt
Clinical Trials on drenovac handcrafted
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)Completed